Full Episode
Friday, Sep 5
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

pharmaceuticals

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Aug 29

Watch 7:41
Did outcry on social media lead to Mylan’s generic EpiPen?

By PBS News Hour

After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New…

Continue watching

Feb 10

Lower drug prices: Does any candidate have an Rx?

By Philip Moeller

The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.

Continue reading

Jul 06

At least 7 states limit patient costs for high-priced drugs

By Michael Ollove, Stateline

As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the financial pain for patients who need medicine that can cost up to hundreds of…

Continue reading

May 12

High price tag puts Hepatitis-C cure out of reach for boomers on Medicare

By Richard Knox, NPR

A growing number of people who got infected in the 1960s through the 1990s have now "used up" the infection's latency period, notes Dr. Camilla Graham of Beth Israel Deaconess Hospital in Boston, "which is why we're now seeing this…

Continue reading

Dec 17

Watch
No image
Should doctors be paid by pharmaceutical companies to promote their drugs?

Should doctors be paid by pharmaceutical companies to promote their drugs?…

Continue watching

Nov 09

Watch
No image
Maine’s prescription for drug savings: Go foreign

Drug companies and the State of Maine battle over the importation of prescription drugs.

Continue watching

Apr 12

Watch
No image
Coming Soon: China’s Health Care Reform

NewsHour special correspondent Jeffrey Kaye reports on China's health care reform.

Continue watching

Sep 01

Watch
No image
FDA’s Safety Role in Question After Egg Recall

A massive egg recall over fears of a salmonella outbreak raises new questions on whether the Food and Drug Administration can handle its regulatory role. Betty Ann Bowser has more.

Continue watching

Jump to the First Page Previous Page
1 2
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Sep 5
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You